![](/img/cover-not-exists.png)
Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study
Tsuru, Tomomi, Tanaka, Yoshiya, Kishimoto, Mitsumasa, Saito, Kazuyoshi, Yoshizawa, Seiji, Takasaki, Yoshinari, Miyamura, Tomoya, Niiro, Hiroaki, Morimoto, Shinji, Yamamoto, Junichi, Lledo-Garcia, RociLanguage:
english
Journal:
Modern Rheumatology
DOI:
10.3109/14397595.2015.1079292
Date:
October, 2015
File:
PDF, 671 KB
english, 2015